Shanghai Henlius Biotech's Anti-Lung Cancer Injection Gets European Commission's Approval

MT Newswires Live02-06

Shanghai Henlius Biotech's (HKG:2696) serplulimab injection in combination with carboplatin and etoposide has been approved by the European Commission for the first-line treatment of adult patients with extensive-stage small cell lung cancer, a Wednesday bourse filing said.

The injection is an anti-PD-1 monoclonal antibody used for the treatment of various types of lung cancer. It has been approved in mainland China to be used in combination with chemotherapy.

The injection will be deployed in Europe under the trade name Hetronifly. The approval implies a centralized marketing authorization for the injection for all the EU member states together with Iceland, Liechtenstein, and Norway.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2509249148?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-06 16:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509249148","market":"us","top_or_hot":-1,"title":"Shanghai Henlius Biotech's Anti-Lung Cancer Injection Gets European Commission's Approval","media":"MT Newswires Live","content":"<html><body><p> Shanghai Henlius Biotech's (HKG:2696) serplulimab injection in combination with carboplatin and etoposide has been approved by the European Commission for the first-line treatment of adult patients with extensive-stage small cell lung cancer, a Wednesday bourse filing said.</p><p>The injection is an anti-PD-1 monoclonal antibody used for the treatment of various types of lung cancer. It has been approved in mainland China to be used in combination with chemotherapy.</p><p>The injection will be deployed in Europe under the trade name Hetronifly. The approval implies a centralized marketing authorization for the injection for all the EU member states together with Iceland, Liechtenstein, and Norway.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Henlius Biotech's Anti-Lung Cancer Injection Gets European Commission's Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Henlius Biotech's Anti-Lung Cancer Injection Gets European Commission's Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-06 16:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Shanghai Henlius Biotech's (HKG:2696) serplulimab injection in combination with carboplatin and etoposide has been approved by the European Commission for the first-line treatment of adult patients with extensive-stage small cell lung cancer, a Wednesday bourse filing said.</p><p>The injection is an anti-PD-1 monoclonal antibody used for the treatment of various types of lung cancer. It has been approved in mainland China to be used in combination with chemotherapy.</p><p>The injection will be deployed in Europe under the trade name Hetronifly. The approval implies a centralized marketing authorization for the injection for all the EU member states together with Iceland, Liechtenstein, and Norway.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2509249148","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509249148","pubTimestamp":1738830830,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Henlius Biotech's  serplulimab injection in combination with carboplatin and etoposide has been approved by the European Commission for the first-line treatment of adult patients with extensive-stage small cell lung cancer, a Wednesday bourse filing said.The injection is an anti-PD-1 monoclonal antibody used for the treatment of various types of lung cancer. It has been approved in mainland China to be used in combination with chemotherapy.The injection will be deployed in Europe under the trade name Hetronifly. The approval implies a centralized marketing authorization for the injection for all the EU member states together with Iceland, Liechtenstein, and Norway.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02696":"复宏汉霖"},"translate_title":"上海复宏汉霖生物抗肺癌注射液获欧盟委员会批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02696":1},"content_text":"Shanghai Henlius Biotech's (HKG:2696) serplulimab injection in combination with carboplatin and etoposide has been approved by the European Commission for the first-line treatment of adult patients with extensive-stage small cell lung cancer, a Wednesday bourse filing said.The injection is an anti-PD-1 monoclonal antibody used for the treatment of various types of lung cancer. It has been approved in mainland China to be used in combination with chemotherapy.The injection will be deployed in Europe under the trade name Hetronifly. The approval implies a centralized marketing authorization for the injection for all the EU member states together with Iceland, Liechtenstein, and Norway.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2509249148"}